• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of archdischArchives of Disease in ChildhoodVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Arch Dis Child. Apr 1973; 48(4): 305–312.
PMCID: PMC1648332

Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis*

Abstract

Nalidixic acid is effective in vitro against shigellae including strains multiply-resistant to antibiotics. A comparative study of acute shigellosis in infants and children involved 19 patients treated with ampicillin and 17 treated with nalidixic acid. Stool cultures remained positive longer with nalidixic acid treatment than with ampicillin therapy, and clinical response was slower. The rate of response to therapy was correlated with the serum levels of ampicillin. Though nalidixic acid eliminates shigellae from stools more rapidly than with symptomatic therapy alone, it cannot be recommended for routine treatment of acute shigellosis since it has little effect on the natural course of the illness. In special circumstances when dealing with shigellae that are resistant to ampicillin, tetracycline, and chloramphenicol, nalidixic acid may have a limited use.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • AKBARI A, WARD JN, HILF MM, LAVENGOOD RW, DRAPER JW. NEGGRAM (NALIDIXIC ACID) IN THE TREATMENT OF URINARY INFECTIONS. J Urol. 1964 Nov;92:552–554. [PubMed]
  • BARLOW AM. NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS. Br Med J. 1963 Nov 23;2(5368):1308–1310. [PMC free article] [PubMed]
  • Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed]
  • CARROLL G. NEGGRAM (NALIDIXIC ACID): A NEW ANTIMICROBIAL CHEMOTHERAPEUTIC AGENT. J Urol. 1963 Oct;90:476–478. [PubMed]
  • Davies JR, Farrant WN, Uttley AH. Antibiotic resistance of Shigella sonnei. Lancet. 1970 Dec 5;2(7684):1157–1159. [PubMed]
  • Farrar WE, Jr, Eidson M. Antibiotic resistance in Shigella mediated by R factors. J Infect Dis. 1971 May;123(5):477–484. [PubMed]
  • Fernandez LA. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid. J Kans Med Soc. 1966 Jul;67(7):359–passim. [PubMed]
  • Haltalin KC, Kusmiesz HT, Hinton LV, Nelson JD. Treatment of acute diarrhea in outpatients. Double-blind study comparing ampicillin and placebo. Am J Dis Child. 1972 Oct;124(4):554–561. [PubMed]
  • HALTALIN KC, NELSON JD. IN VITRO SUSCEPTIBILITY OF SHIGELLAE TO SODIUM SULFADIAZINE AND TO EIGHT ANTIBIOTICS. JAMA. 1965 Aug 30;193:705–710. [PubMed]
  • Haltalin KC, Nelson JD. Failure of furazolidone therapy in shigellosis. Am J Dis Child. 1972 Jan;123(1):40–44. [PubMed]
  • Haltalin KC, Nelson JD, Hinton LV, Kusmiesz HT, Sladoje M. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin. J Pediatr. 1968 May;72(5):708–720. [PubMed]
  • Haltalin KC, Nelson JD, Kusmiesz HT, Hinton LV. Comparison of intramuscular and oral ampicillin therapy for shigellosis. J Pediatr. 1968 Oct;73(4):617–622. [PubMed]
  • JAWETZ E. Assay of antibacterial activity in serum. A useful guide for complex antimicrobial therapy. Am J Dis Child. 1962 Jan;103:81–84. [PubMed]
  • Nelson JD, Haltalin KC. In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications. Ann N Y Acad Sci. 1966 Jun 14;132(2):1006–1012. [PubMed]
  • Nelson JD, Haltalin KC. In vitro effectiveness of four cephalosporins against Shigellae and clinical ineffectiveness of cephaloglycin. Chemotherapy. 1972;17(1):40–50. [PubMed]
  • Nelson JD, Shelton S, Kusmiesz HT, Haltalin KC. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):879–886. [PubMed]
  • Ross S, Controni G, Khan W. Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications. JAMA. 1972 Jul 3;221(1):45–47. [PubMed]
  • Simon HJ, Yin EJ. Microbioassay of antimicrobial agents. Appl Microbiol. 1970 Apr;19(4):573–579. [PMC free article] [PubMed]
  • THOMPSON RE, RAE J. NEGRAM (1-ETHYL-7-METHYL-1,8-NAPHTHYRIDINE-4-ONE-3-CARBOXYLIC ACID): A NEW ANTIBACTERIAL AGENT FOR THE TREATMENT OF URINARY INFECTION. REPORT OF A TRIAL IN GENERAL PRACTICE. Br J Urol. 1964 Mar;36:42–47. [PubMed]
  • Yu PC, Chen HS. A clinical study of wintomylon in the treatment of shigellosis. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1965 Jul-Sep;6(3):127–131. [PubMed]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...